Postgraduate research

Development of a toolkit to improve prescribing appropriateness for children with epilepsy

Qualification: PhD

Department: School of Healthcare

Application deadline: 30 June 2024

Start date: 23 September 2024

Overview

Supervisors:

Project Description :

3 Year Funded PhD open to UK/Home applicants only

Background

 Adherence to medication in children and young people (CYP) with epilepsy measured by objective assessment is estimated to be 58%(1) with non-adherence to medication closely associated with poorer seizure outcomes.(2)

Evidence from randomised controlled trials suggest that medication adherence may be improved through education and behavioural interventions.(3, 4) Better quality trials with longer follow up periods are however recommended.(4)  Theory informed and developed interventions have not been trialled in this population and there is limited evidence understanding of how children and young people (CYP) self-manage their therapy.(5)  CYP might be traditionally viewed as disempowered and therefore less likely to be engaged in concordance with a treatment plan but increasingly agreement in treatment plans is recognised as an important factor (6).

To develop effective intervention to improve medication adherence in CYP it is therefore important to understand barriers and enablers, including both physical and non-physical to medication adherence.  Socioeconomic factors such as parental education, annual income and marital status are all known to be related to non-adherence.(7) The impact of types of medication and numbers of medication on non-adherence is however less clear.(1) With increasing numbers of CYP focused medication formulations becoming routinely available, opportunities to improve medication adherence through better prescribing decisions and formulation selection may require inclusion in the design of future complex interventions for CYP with epilepsy.

The aim of the project is to develop a toolkit for prescribers to enhance the appropriateness of prescribing and support for children and young people with epilepsy to improve medication adherence.

Method

 This PhD will be designed to identify the barriers and enablers to epilepsy non-adherence in CYP through the systematic review of the literature, qualitative research methods and potentially analysis of big-data.  A large-scale survey of CYP with epilepsy may be included to ensure generalisability of findings.

Having identified a range of barriers and enablers to medication adherence; the PhD student will work with CYP with epilepsy to co-create and design a complex intervention for evaluation within a future feasibility study and definitive trial.

References

  1. Yang C, Hao Z, Yu D, Xu Q, Zhang L. The prevalence rates of medication adherence and factors influencing adherence to antiepileptic drugs in children with epilepsy: A systematic review and meta analysis. Epilepsy Res. 2018;142:88-99.
  2. Modi AC, Wu YP, Rausch JR, Peugh JL, Glauser TA. Antiepileptic drug nonadherence predicts pediatric epilepsy seizure outcomes. Neurology. 2014;83(22):2085-90.
  3. Godara K, Phakey N, Garg D, Sharma S, Das RR. Interventions to Improve Medication Adherence in Children With Epilepsy: A Systematic Review. Cureus. 2024.
  4. Al-Aqeel S, Gershuni O, Al-Sabhan J, Hiligsmann M. Strategies for improving adherence to antiepileptic drug treatment in people with epilepsy. Cochrane Database of Systematic Reviews. 2017.
  5. Mooney O, McNicholl A, Lambert V, Gallagher P. Self-management in children and young people with epilepsy: A systematic review and qualitative meta-synthesis. J Health Psychol. 2021;26(1):126-39.
  6. Sanz EJ. Concordance and children's use of medicines. BMJ. 2003 Oct 11;327(7419):858-60. doi: 10.1136/bmj.327.7419.858. PMID: 14551105; PMCID: PMC214037.
  7. Huber R, Weber P. Is there a relationship between socioeconomic factors and prevalence, adherence and outcome in childhood epilepsy? A systematic scoping review. Eur J Paediatr Neurol. 2022;38:1-6.

Funding

Funding

The Desitin Pharma funded studentship provides:

  • 3 years UK/Home Tuition Fees
  • 3 Years Stipend at UKRI rates (2024/5 £19,237 per yer)

Up to 3k per annum is also available to cover travel and consumables.

Entry requirements

Entry requirements

Applicants are required to hold/or expect to obtain a UK Bachelor Degree 2:1 or better in a relevant healthcare subject e.g. pharmacy or nursing. Or overseas equivalent.

The University of Leicester English language requirements apply.

 

Informal enquiries

Informal enquiries

Project enquiries to Professor David Wright d.j.wright@leicester.ac.uk

General enquiries to SOH-PGR@le.ac.uk

How to apply

How to apply

To apply, please use the Apply button at the bottom of the page and select September 2024 from the dropdown menu.

With your application, please include:

  • CV
  • Personal statement explaining your interest in the project, your experience and why we should consider you
  • Degree certificates and transcripts of study already completed and if possible transcript to date of study currently being undertaken
  • Evidence of English language proficiency if applicable
  • In the reference section please enter the contact details of your two academic referees in the boxes provided or upload letters of reference if already available.
  • In the funding section please specify that you wish to be considered for the SOH Wright
  • In the proposal section please provide the name of the project supervisors and project title you want to be considered for. (we do not require a proposal)

Eligibility

Eligibility

The studentship is open to UK applicants only.

*EU applicants who hold EU settled or EU pre-settled status please provide PGR Admissions with a share code (the one that starts with S) so we can verify your fee status email to pgradmissions@le.ac.uk. Please include your PhD application number.

Application options

PhD Healthcare Apply now

Back to top
MENU